Abbott Laboratories (Pakistan) (KAR:ABOT) Market Cap : ₨67,551 Mil (As of Jun. 07, 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Abbott Laboratories (Pakistan)'s share price for the quarter that ended in Mar. 2024 was ₨478.83. Abbott Laboratories (Pakistan)'s Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 98 Mil. Therefore, Abbott Laboratories (Pakistan)'s market cap for the quarter that ended in Mar. 2024 was ₨46,878 Mil.

Abbott Laboratories (Pakistan)'s quarterly market cap increased from Sep. 2023 (₨33,874 Mil) to Dec. 2023 (₨45,055 Mil) and increased from Dec. 2023 (₨45,055 Mil) to Mar. 2024 (₨46,878 Mil).

Abbott Laboratories (Pakistan)'s annual market cap declined from Dec. 2021 (₨70,244 Mil) to Dec. 2022 (₨45,358 Mil) and declined from Dec. 2022 (₨45,358 Mil) to Dec. 2023 (₨45,055 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Abbott Laboratories (Pakistan)'s Enterprise Value for Today is ₨64,291 Mil.

Abbott Laboratories (Pakistan) Market Cap Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Market Cap Chart

Abbott Laboratories (Pakistan) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

43,739.90

73,950.95

70,244.44

45,358.19

45,054.70

Abbott Laboratories (Pakistan) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															40,458.28	36,223.11	33,874.48	45,054.70	46,877.60

Competitive Comparison of Abbott Laboratories (Pakistan)'s Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories (Pakistan)'s Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Market Cap distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Market Cap falls into.

Abbott Laboratories (Pakistan) Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Abbott Laboratories (Pakistan)'s Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	₨460.21	*	97.9003
	=	₨45,055

Abbott Laboratories (Pakistan)'s Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	₨478.83	*	97.9003
	=	₨46,878

Abbott Laboratories (Pakistan) (KAR:ABOT) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Abbott Laboratories (Pakistan) Market Cap Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines